BioLife Solutions

Yahoo Finance • last month

BioLife Solutions shareholders re-elect board, approve executive pay and auditor

BioLife Solutions, Inc. (NASDAQ:BLFS) held its 2025 annual meeting of stockholders on Wednesday. According to a press release statement based on an SEC filing, shareholders re-elected all seven director nominees to the board, approved exec... Full story

Yahoo Finance • 2 months ago

BioLife Solutions raises 2025 revenue guidance to $100M–$103M as cell processing momentum accelerates

Earnings Call Insights: BioLife Solutions (BLFS) Q2 2025 MANAGEMENT VIEW * CEO Roderick de Greef reported, "We delivered another strong quarter as our team continues to execute and build on the momentum established over the last severa... Full story

Yahoo Finance • 3 years ago

BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2022 Earnings Call Transcript

BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Good day, and welcome to the BioLife Solutions' Fourth Quarter 2022 and Full Year Earnings Call. Today's call is being recorded. I would now l... Full story

Yahoo Finance • 3 years ago

BioLife Solutions Launches Ultraguard™ -70°C Phase Change Material (PCM) Accessory to Provide Backup Cooling in ULT Freezers and Dry Ice Alternative for Benchtop Biologic Material Storage

Exclusive global supplier of non-toxic, non-flammable PCM; first to operate at -70°C, meeting critical temperature requirement of biologic materials. BOTHELL, Wash., March 1, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a... Full story

Yahoo Finance • 3 years ago

iVexSol® Closes $23.8M Series A-3 Financing; Funds to Revolutionize the Production of Lentiviral Vectors

LEXINGTON, Mass., Jan. 26, 2023 (GLOBE NEWSWIRE) -- iVexSol Inc., a technology-based lentiviral vector (LVV) contract development and manufacturing organization (CDMO), announced $23.8 million in Series A-3 funding. New investors Bristol... Full story

Yahoo Finance • 3 years ago

BioLife Solutions to Announce Preliminary 2022 Revenue and Introduce 2023 Revenue Guidance on January 9, 2023

Announcement Precedes Meetings to be Held During the J.P. Morgan Health Care Conference; Updated Investor Presentation Demonstrates Continued Execution to Drive High-Margin, Recurring Revenue BOTHELL, Wash., Dec. 19, 2022 /PRNewswire/ --... Full story